Weaver Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Hold
2,308
0.11% 122
2026
Q1
$518K Sell
2,308
-75
-3% -$18.7K 0.11% 124
2025
Q4
$574K Sell
2,383
-277
-10% -$70.8K 0.12% 129
2025
Q3
$728K Sell
2,660
-57
-2% -$15.6K 0.16% 115
2025
Q2
$701K Sell
2,717
-12
-0.4% -$2.86K 0.17% 115
2025
Q1
$611K Buy
2,729
+21
+0.8% +$4.9K 0.16% 120
2024
Q4
$619K Buy
2,708
+636
+31% +$153K 0.17% 121
2024
Q3
$506K Buy
2,072
+437
+27% +$97.6K 0.15% 119
2024
Q2
$313K Buy
+1,635
New +$332K 0.1% 136

Other funds holding RMD

Weaver Capital Management's RMD Position: Q2 2026 in Review

Weaver Capital Management held its ResMed (RMD) position steady in Q2 2026 at 2,308 shares worth $518K. The position accounts for 0.11% of the portfolio, ranked #122.

Weaver Capital Management first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $728K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Weaver Capital Management held 2,308 shares of ResMed worth $518K as of Q2 2026.
  • Weaver Capital Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.11% of Weaver Capital Management's portfolio in Q2 2026, its #122 holding.
  • Weaver Capital Management first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Weaver Capital Management's ResMed position peaked at $728K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Weaver Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.